News and Features
infoSIDA Launches Redesigned Home Page!
infoSIDA is proud to announce a new and improved home page design. infoSIDA is the Spanish-language sister site of AIDSinfo and offers information about HIV treatment and clinical trials. All content is available in Spanish and created specifically for patients. The site offers patient-level fact sheets, clinical trial information, a glossary of HIV-related terms, and much more. Additionally, Spanish-speaking health information specialists are available to answer questions by phone at 1-800-448-0440 (M-F, 12-5 pm), online via Live Help (M-F, 12-4 pm), or by e-mail (ContactUs@aidsinfo.nih.gov).
infoSIDA al instante, the Spanish-language infoSIDA e-newsletter, is now available for easy access from the infoSIDA home page. In addition, a new features section has been added with quick links to popular infoSIDA tools and resources.
More information from infoSIDA is available:
- infoSIDA Home page
- infoSIDA al instante Listserv
- Live Help
- Fact Sheets
- Drug database
- Clinical Trials Database search
- Glossary of HIV-related terms
- Glossary Translation Tool
Virologically Suppressed Patients Have Fewer HIV Treatment Regimen Changes Due to Side Effects
In a recent study, researchers found that the rate of HIV regimen change due to side effects is relatively low in virologically suppressed patients--approximately 39% of 508 study participants--and that certain regimens are associated with even fewer treatment changes.
Specifically, treatment regimen combinations that were less likely to be changed due to toxicity included atazanavir, efavirenz, or tenofovir, while there was an increased risk of change due to toxicity in regimens containing lopinavir/ritonavir or stavudine. Several demographic factors were also found to be associated with regimen change. Study results indicate that certain regimens have the potential for long-term use if treatment toxicities are minimized.
More information is available: